http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-202008189-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a004189d68f503940b7ab74bc9696a8c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c232aa93509d6048dc18a484df17b17f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff34c425de4ec1c256da183754ef7ae3
publicationDate 2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-202008189-A2
titleOfInvention New Use in Olive Oil to Change Mitochondria Membrane Potential
abstract The invention, with less side effects, reducing mitochondrial damage and changing the membrane potential, can be used in ischemia (lack of oxygen), hypoxia (oxygen deficiency), oxidative phosphorylation inhibition or decrease and oxidative damage, and also changes the metabolic rate by changing the membrane potential. It is about a product that can provide, can also be used as a metabolism regulator. The product of the invention is used as a carrier or base formulation in the treatment and / or support for treatment in degenerative and autoimmune diseases that cause hypoxia, oxidative stress and / or impair mitochondrial membrane activation.
priorityDate 2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 18.